工程菌检测肿瘤 DNA。
Engineered bacteria detect tumor DNA.
机构信息
Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA.
Precision Cancer Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.
出版信息
Science. 2023 Aug 11;381(6658):682-686. doi: 10.1126/science.adf3974. Epub 2023 Aug 10.
Abstract
Synthetic biology has developed sophisticated cellular biosensors to detect and respond to human disease. However, biosensors have not yet been engineered to detect specific extracellular DNA sequences and mutations. Here, we engineered naturally competent to detect donor DNA from the genomes of colorectal cancer (CRC) cells, organoids, and tumors. We characterized the functionality of the biosensors in vitro with coculture assays and then validated them in vivo with sensor bacteria delivered to mice harboring colorectal tumors. We observed horizontal gene transfer from the tumor to the sensor bacteria in our mouse model of CRC. This cellular assay for targeted, CRISPR-discriminated horizontal gene transfer (CATCH) enables the biodetection of specific cell-free DNA.
摘要
合成生物学已经开发出复杂的细胞生物传感器来检测和响应人类疾病。然而，生物传感器尚未被设计用于检测特定的细胞外 DNA 序列和突变。在这里，我们构建了天然感受态的，以检测来自结直肠癌 (CRC) 细胞、类器官和肿瘤基因组的供体 DNA。我们在体外通过共培养实验来表征生物传感器的功能，然后通过将传感器细菌递送到携带结直肠肿瘤的小鼠中来验证其在体内的功能。我们在 CRC 的小鼠模型中观察到了来自肿瘤的水平基因转移到传感器细菌中。这种针对特定 CRISPR 区分的水平基因转移 (CATCH) 的细胞分析方法可实现对特定游离 DNA 的生物检测。
相似文献
1
Engineered bacteria detect tumor DNA.工程菌检测肿瘤 DNA。
Science. 2023 Aug 11;381(6658):682-686. doi: 10.1126/science.adf3974. Epub 2023 Aug 10.
2
Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.液体活检分析结直肠癌相关突变：循环无细胞 DNA 和循环肿瘤细胞的应用。
Cancer Sci. 2019 Nov;110(11):3497-3509. doi: 10.1111/cas.14186. Epub 2019 Sep 18.
3
Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer.结直肠癌基因和表观遗传生物标志物检测的当前进展
Biosens Bioelectron. 2023 Nov 1;239:115611. doi: 10.1016/j.bios.2023.115611. Epub 2023 Aug 19.
4
Direct plasmonic detection of circulating RAS mutated DNA in colorectal cancer patients.直接等离子体检测结直肠癌患者循环 RAS 突变 DNA。
Biosens Bioelectron. 2020 Dec 15;170:112648. doi: 10.1016/j.bios.2020.112648. Epub 2020 Sep 25.
5
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.在突变型 KRAS 的结直肠癌细胞中，SLC25A22 介导的谷氨酰胺分解作用降低 DNA 去甲基化以增加 WNT 信号、干性和耐药性。
Gastroenterology. 2020 Dec;159(6):2163-2180.e6. doi: 10.1053/j.gastro.2020.08.016. Epub 2020 Aug 16.
6
Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.检测结直肠癌患者循环游离 DNA 中的突变与疾病分期的关系。
Cancer Med. 2019 Jul;8(8):3761-3769. doi: 10.1002/cam4.2219. Epub 2019 May 27.
7
Reduced Mutation Rate and Increased Transformability of Transposon-Free Acinetobacter baylyi ADP1-ISx.无转座子拜氏不动杆菌ADP1-ISx的突变率降低及转化能力增强
Appl Environ Microbiol. 2017 Aug 17;83(17). doi: 10.1128/AEM.01025-17. Print 2017 Sep 1.
8
Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome.耐抗生素的鲍曼不动杆菌通过生菜向大肠杆菌的水平基因转移及其随后对肠道微生物组的抗生素抗性传播。
mSphere. 2020 May 27;5(3):e00329-20. doi: 10.1128/mSphere.00329-20.
9
Lack of detectable DNA uptake by bacterial gut isolates grown in vitro and by Acinetobacter baylyi colonizing rodents in vivo.体外培养的肠道细菌分离株以及体内定殖于啮齿动物的拜氏不动杆菌均未检测到DNA摄取。
Environ Biosafety Res. 2007 Jan-Jun;6(1-2):149-60. doi: 10.1051/ebr:2007029. Epub 2007 Oct 26.
10
CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.CRISPR-Cas9 介导的肠道肿瘤类器官基因敲除为结直肠癌驱动基因提供功能验证。
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15635-15644. doi: 10.1073/pnas.1904714116. Epub 2019 Jul 12.
引用本文的文献
1
Engineering the Microbiome: a Novel Approach to Managing Autoimmune Diseases.工程化微生物群：一种治疗自身免疫性疾病的新方法。
Neuromolecular Med. 2025 Sep 5;27(1):63. doi: 10.1007/s12017-025-08879-5.
2
Ingestible optoelectronic capsules enable bidirectional communication with engineered microbes for controllable therapeutic interventions.可摄入的光电胶囊能够与工程微生物进行双向通信，以实现可控的治疗干预。
Nat Microbiol. 2025 Aug;10(8):1841-1853. doi: 10.1038/s41564-025-02057-w. Epub 2025 Jul 28.
3
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群：机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
4
A discovery platform for identification of host-induced bacterial biosensors from diverse sources.一个用于从多种来源鉴定宿主诱导型细菌生物传感器的发现平台。
Mol Syst Biol. 2025 Jun 9. doi: 10.1038/s44320-025-00123-3.
5
Mechanistic Foundations of KRAS-Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment.KRAS驱动的肿瘤生态系统的机制基础：整合免疫、代谢、微生物和基质微环境之间的相互作用
Adv Sci (Weinh). 2025 Jun 9:e02714. doi: 10.1002/advs.202502714.
6
Innovative applications and research advances of bacterial biosensors in medicine.细菌生物传感器在医学中的创新应用与研究进展
Front Microbiol. 2025 Apr 23;16:1507491. doi: 10.3389/fmicb.2025.1507491. eCollection 2025.
7
Chimeric Nanozyme Bacterial Outer Membrane Vesicles Reprograming Tumor Microenvironment for Safe and Efficient Anticancer Therapy.嵌合纳米酶细菌外膜囊泡重编程肿瘤微环境以实现安全有效的抗癌治疗
Adv Sci (Weinh). 2025 Jun;12(22):e2417712. doi: 10.1002/advs.202417712. Epub 2025 Apr 25.
8
Development of ultrasound-visualized tumor-targeting engineered bacteria for precise tumor therapy.用于精确肿瘤治疗的超声可视化肿瘤靶向工程菌的研发。
Synth Syst Biotechnol. 2025 Apr 1;10(3):774-782. doi: 10.1016/j.synbio.2025.03.009. eCollection 2025 Sep.
9
The oncobiome; what, so what, now what?肿瘤微生物组；是什么、为何重要、又该如何应对？
Microbiome Res Rep. 2025 Feb 27;4(1):16. doi: 10.20517/mrr.2024.89. eCollection 2025.
10
The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions.肠道微生物群与结直肠癌：理解两者之间的联系并探索治疗干预措施。
Biology (Basel). 2025 Feb 28;14(3):251. doi: 10.3390/biology14030251.
本文引用的文献
1
The microbiome and human cancer.微生物组与人类癌症。
Science. 2021 Mar 26;371(6536). doi: 10.1126/science.abc4552.
2
Application of Next Generation Sequencing in Laboratory Medicine.下一代测序在医学实验室中的应用。
Ann Lab Med. 2021 Jan;41(1):25-43. doi: 10.3343/alm.2021.41.1.25. Epub 2020 Aug 25.
3
One-Day Construction of Multiplex Arrays to Harness Natural CRISPR-Cas Systems.一天内构建多重阵列以利用自然 CRISPR-Cas 系统。
ACS Synth Biol. 2020 May 15;9(5):1129-1137. doi: 10.1021/acssynbio.9b00489. Epub 2020 Apr 22.
4
Not all mutations of predict poor prognosis in patients with colorectal cancer.并非所有的[具体基因名称未给出]突变都预示着结直肠癌患者预后不良。
Int J Clin Exp Pathol. 2019 Mar 1;12(3):957-967. eCollection 2019.
5
Pan-cancer whole-genome analyses of metastatic solid tumours.泛癌种实体瘤全基因组分析。
Nature. 2019 Nov;575(7781):210-216. doi: 10.1038/s41586-019-1689-y. Epub 2019 Oct 23.
6
Synthetic gene circuits for the detection, elimination and prevention of disease.用于疾病检测、消除和预防的合成基因电路。
Nat Biomed Eng. 2018 Jun;2(6):399-415. doi: 10.1038/s41551-018-0215-0. Epub 2018 Jun 11.
7
Probiotic strains detect and suppress cholera in mice.益生菌菌株可检测并抑制小鼠霍乱。
Sci Transl Med. 2018 Jun 13;10(445). doi: 10.1126/scitranslmed.aao2586.
8
An ingestible bacterial-electronic system to monitor gastrointestinal health.一种可摄入的细菌-电子系统，用于监测胃肠道健康。
Science. 2018 May 25;360(6391):915-918. doi: 10.1126/science.aas9315.
9
Field-deployable viral diagnostics using CRISPR-Cas13.现场部署的基于 CRISPR-Cas13 的病毒诊断方法
Science. 2018 Apr 27;360(6387):444-448. doi: 10.1126/science.aas8836.
10
Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.对结肠类器官进行基因编辑提供了一个分子上不同且原位的锯齿状癌发生的临床前模型。
Gut. 2019 Apr;68(4):684-692. doi: 10.1136/gutjnl-2017-315920. Epub 2018 Apr 17.
Zotero 插件